Raveendra S Dayam

Title: Raveendra S Dayam: Innovator in HIV/AIDS Therapeutics

Introduction

Raveendra S Dayam is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of HIV/AIDS therapeutics, holding 2 patents that focus on innovative compounds and methodologies for combating this global health issue.

Latest Patents

His latest patents include "Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics." This patent describes pharmacophore models that can be utilized in drug design and discovery. It presents an in silico protocol along with in vitro assays. The compounds and their pharmaceutically acceptable salts exhibit HIV-1 integrase inhibitory and anti-HIV activity, which can be used in the treatment of HIV/AIDS and related infections, either alone or in combination with existing antiretroviral therapeutics. Another notable patent is "Integrin-binding small molecules," which relates to compositions containing integrin-binding small molecules. This invention also discloses methods for binding integrins to these small molecules and identifying small molecules that bind to integrins.

Career Highlights

Raveendra S Dayam is affiliated with the University of Southern California, where he continues to advance research in the field of HIV/AIDS therapeutics. His work is characterized by a commitment to developing effective treatments that can significantly improve patient outcomes.

Collaborations

He collaborates with Nouri Neamati, a fellow researcher, to further enhance the impact of their work in the field of HIV/AIDS.

Conclusion

Raveendra S Dayam's innovative contributions to HIV/AIDS therapeutics highlight his dedication to addressing critical health challenges. His patents reflect a deep understanding of drug design and the potential for new treatments in the fight against HIV/AIDS.